基本信息
views: 0
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Among my efforts to optimize the management of headache disorders, I have developed and executed the first controlled trials investigating the effects and mechanisms of action of psilocybin in cluster, migraine, and post-traumatic headache. Previously, I studied the neuropharmacology of psychedelics and other serotonergic compounds in the context of receptor binding and intracellular signaling. Currently, I’m seeking to identify the source of sustained reductions in headache burden after limited dosing of psychedelic and related compounds, considering several neurobiological systems involved in both headache pathology and the known actions of psychedelic compounds.
Another endeavor of mine is to enhance the understanding of and improve the lives of patients with cluster headache, a severely painful headache disorder also known as “suicide headache.” Recognition and proper management of this condition is woefully lacking. While novel therapies are finally emerging, further research is desperately needed. In addition to better treatments, basic gold-standard therapies, such as inhaled oxygen, remain out of reach for many patients. Education on many levels, including federal regulatory bodies, is required to best serve this patient population that itself has demonstrated immense resilience and optimism in the face of their disease.
Another endeavor of mine is to enhance the understanding of and improve the lives of patients with cluster headache, a severely painful headache disorder also known as “suicide headache.” Recognition and proper management of this condition is woefully lacking. While novel therapies are finally emerging, further research is desperately needed. In addition to better treatments, basic gold-standard therapies, such as inhaled oxygen, remain out of reach for many patients. Education on many levels, including federal regulatory bodies, is required to best serve this patient population that itself has demonstrated immense resilience and optimism in the face of their disease.
Research Interests
Papers共 36 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Current Neurology and Neuroscience Reportspp.1-14, (2024)
Ryan Lanier, Michael Bogenschutz,Emmanuelle Schindler,Benjamin Kelmendi, Caitlyn Durgin,Judy Ashworth
Drug and Alcohol Dependence (2024): 110862
Expert review of neurotherapeuticspp.1-16, (2023)
Frontiers in neurology (2023): 1214969
Current pain and headache reportsno. 9 (2023): 489-495
JOURNAL OF MILITARY VETERAN AND FAMILY HEALTHno. 5 (2023): 88-95
Expert Review of Neurotherapeuticsno. 10 (2023): 867-882
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn